UNC’s Norman Sharpless Named NCI Director; Senators Back to Work on Healthcare Bill; National Institutes of Health Director to Remain
On June 12, 2017, President Trump named Norman Sharpless, MD, as director of National Cancer Institute (NCI). Sharpless, formerly the director of the Lineberger Comprehensive Cancer Center at the University of North Carolina, is a practicing oncologist and cancer researcher. He will take over as for Doug Lowry, MD, who has been the NCI’s acting director since 2015.
Bipartisan Cancer Parity Drug Legislation Introduced in U.S. Congress
Two members of the House of Representatives have put political party differences aside and introduced bipartisan legislation that requires health insurers to cover traditional chemotherapy, along with oral medications associated with cancer treatment. U.S. Representatives Leonard Lance (R-NJ) and Brian Higgins (D-NY) have proposed the Cancer Drug Parity Act (H.R. 1409). The intent of the bill is to ensure appropriate oncologic treatments are affordable and covered for patients with cancer.
Presidential Personnel Appointments That Affect Healthcare Policy
There is a difference between campaigning and governing. Running for office is about putting out bold ideas and galvanizing a base of supporters who are energized by the opportunity for real change. It’s exhilarating and fluid. The momentum can be like a rock concert, and people are carried away with excitement about the future.
Trump Budget Proposal Cuts Healthcare Spending, Research; GOP’s Healthcare Bill Faces Stiff Resistance
On March 15, 2017, the Trump administration released its first budget proposal, slashing federal spending in many areas of health care, education, environmental protection, and the sciences while increasing funding for defense and homeland security. The proposed budget would decrease spending for the Department of Health and Human Services by nearly 18%, which includes a 20% budget cut for the National Institutes of Health (NIH)—a decrease of nearly $6 billion. This stands to impact a number of cancer-related research programs developing new treatments and drugs through NIH funding.
Biden Foundation to Continue Cancer Moonshot Work
To a crowd of more than 1,300 attendees at the South by Southwest Conference (SXSW) in Austin, TX, on March 12, 2017, former Vice President Joe Biden announced that the Biden Foundation, his new nonprofit organization, would be continuing the work of the National Cancer Moonshot Initiative, which he led during his final year as vice president.
Opportunities Exist for Health Policy Compromise in 2017
The 115th U.S. Congress was sworn into office on January 3, 2017. Capitol Hill was abuzz with congratulatory smiles, wide-eyed optimism, and not a small amount of relief for those who survived last November’s election.
Honoring the Legacy of Retiring Congresswoman Lois Capps, RN
Here’s What Oncology Nurses Need to Know About Health Policy Areas of Focus for 2017
As 2017 begins, ONS is hard at work supporting several new policies that could shape health care in the coming months and years. Although the election season has ended, ONS’s ongoing advocacy for oncology nurses and patients with cancer continues.
Your Vote Determines More Than the Presidential Election
New Law and Policies Will Fight Opioid Epidemic
ONS Members Educate Policy Makers About the Need for Pain Management
Discarded Excess U.S. Cancer Drugs Cost $1.8 Billion per Year
What Political Issues Will Affect Oncology Nursing in the 2016 Election?
Congress Passes 2016 Budget With Several Increases to Health and Cancer Spending
In a bipartisan move, Congress successfully passed the $1.15 trillion omnibus spending bill on December 18, 2015 along with a $680 billion tax package to finalize their 2016 budget, which will fund the government until September 30, 2016.